Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

@article{Singh2006CombinationOV,
  title={Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.},
  author={N Heramani Singh and Ajit P Limaye and Graeme Forrest and Nasia Safdar and Patricia Mu{\~n}oz and Kenneth J Pursell and S K Steven Houston and Fernando Rosso and Jos{\'e} G. Montoya and Pamela R Patton and Ramon del Busto and Jose Aguado and Robert A. Fisher and Goran B. G. Klintmalm and Rachel Miller and Marilyn M. Wagener and Russell E Lewis and Dimitrios P Kontoyiannis and S Hamid Husain},
  journal={Transplantation},
  year={2006},
  volume={81 3},
  pages={320-6}
}
BACKGROUND : The efficacy of the combination of voriconazole and caspofungin when used as primary therapy for invasive aspergillosis in organ transplant recipients has not been defined. METHODS : Transplant recipients who received voriconazole and caspofungin (n=40) as primary therapy for invasive aspergillosis (proven or probable) in a prospective multicenter study between 2003 and 2005 were compared to a control group comprising a cohort of consecutive transplant recipients between 1999 and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 111 extracted citations

Antifungal combination therapy for invasive aspergillosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2014
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…